|
|
||||
|
|
||||
|
Our R&D platform includes: The transgenic "Ticcy" mouse --- the first and only current drug response-predictive preclinical animal model of tics, compulsions and hyperactivity, suitable for rapid-throughput screening of prospective therapeutic compounds Discriminating and sensitive novel behavioral analysis methods and software An ongoing academic/basic-research pipeline of concept-stage to preclinically-validated products Corporate research in physics, bioorganic chemistry, physiology, medical device engineering, and nanobiotechnology A Midwest-to-West Coast network of clinical collaborators As scientific advisors, top executives from seven non-affiliated biotech, pharmaceutical, biomedical device and bioinformatics companies
Copyright © 2005, Psyncretis, Inc. All rights reserved. |
products platform about us contacts home
|
|||